₹8,447 crore in medicine overcharging claims remain outstanding as SC seeks wider price controls
The outstanding amount is more than five times the amount realised and accounts for about 84% of the cumulative demand
This is a preview. The full story is available on The Hindu.
Read Full Article on The Hindu

